資源描述:
《慢性腎臟病患者接種乙肝疫苗療效研究.pdf》由會員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。
1、·4l8·中國中砥醫(yī)結(jié)合腎病雜志2015年5月第l6卷第5期CJITWN,May2015,Vo1.16,No.5慢性腎臟病患者接種乙肝疫苗療效研究術(shù)王福珍①吳森超①丘昭文①許春梅①郭春花①林文靜①林沖云①朱杰②王朝暉⑧[摘要]目的:探討慢性腎臟病(chronickidneydisease,CKD)早中期(CKD1—3期)、晚期(CKD4—5期)患者接種乙肝疫苗后的反應(yīng)情況,明確CKD患者接種乙肝疫苗的最佳時(shí)期,使CKD患者產(chǎn)生主動免疫抵御HBV感染。方法:對乙肝兩對半全陰性的慢性腎臟病早中期、晚期患者接種乙肝疫苗,觀察兩組患者乙肝表面抗體的陽轉(zhuǎn)率及抗體滴度高低情況,同時(shí),將CKD
2、早中期組分為接受或未接受激素/免疫抑制劑兩組,所有CKD患者再分為男性、女性兩組,分別對上述分組進(jìn)行比較,觀察各組患者乙肝表面抗體的陽轉(zhuǎn)率及抗體滴度高低情況。結(jié)果:(1)CKD早中期患者接種乙肝疫苗后,乙肝表面抗體陽轉(zhuǎn)率明顯高于CKD晚期患者,且抗體滴度明顯高于CKD晚期組。(2)在CKD早中期組中接受或禾接受激素/免疫抑制荊治療的患者中抗體陽轉(zhuǎn)率差異無統(tǒng)計(jì)學(xué)意義,但接受激素/免疫抑制劑組抗體滴度更高。(3)性別不是影響乙肝疫苗接種效果的因素。結(jié)論:CKD早中期患者接種乙肝疫苗療效優(yōu)于CKD晚期患者,激素及免疫抑制劑治療不影響CKD早中期患者接種乙肝疫苗的療效,性別不影響接種效果
3、。[關(guān)鍵詞]慢性腎臟病乙肝疫苗抗體陽轉(zhuǎn)率ChronicKidneyDiseaesHepatitisBVaccineEficacyWANGFuzhen,W【,Sengchao,QJUZhaowen,etalDepartmentofInternalMedicine,LongyanFirstHospital,F(xiàn)ujianMedicalUniversity,Longyan(364000)ABSTRACTObjective:TocomparetheresponseratetoHBvaccineinCKDstagel-·3patientswiththatinCKDstage4—-5andcl
4、earthebestperiodofhepatitisBvaccinationforpatientswithCKD,whichhelptoproduceactiveimmunizationagainsthepatitisBvirusinfectionforpatientswithCKD.Methods:PatientswithgroupCKD(1~3),andgroupCKD(4—5)wereallvaccinateda—gainsthepatitisBvirusinfection.ThentheantibodyofhepatitisBwasdetected.Atthesamet
5、ime,CKD(1—3)patientsweredividedintotwogroups:Group—A:toaccepthormone/immunosuppressants,Group—B:nottoaccept.AllparticipantswithCKDweredi·videdintotwogroups:maleandfemale.Aftercompletionofthevaccinationschedule,seroconversionandseroprotectionratesineachgroupwereinvestigated.Results:(1)Theseroc
6、onversionrateofpatientswithCKD(1—3)wassignificantlyhigherthanthatofpa—tientswithCKD(4—5),andthedegreeofHBV—AbwassignificantlyhigherthanthatofpatientswithCKD(4—5).(2)TherewasnodifferenceofthepositiverateofHBV—AbandthedegreeofHBV—Abbetweenthetwogroupswhoacceptedordidn’taccepthor—mone/immunosupp
7、ressants.(3)TherewasnosignificantdifferenceoftheeffectofhepatitisBvaccinationbetweenmalesandfe—males.Conclusion:CKD(1~3)patientsshowedhigherresponseratethanpatientswithCKD(4—5).Hormoneandimmunosuppres·santstreatmentdidnotaffecttheeffeetofhepa